ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 151 filers reported holding ANIKA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,979,704 | -7.7% | 749,284 | -7.5% | 0.01% | -16.7% |
Q1 2024 | $20,567,777 | +10.5% | 809,755 | -1.4% | 0.01% | +20.0% |
Q4 2023 | $18,614,101 | +16.2% | 821,452 | -4.5% | 0.01% | 0.0% |
Q3 2023 | $16,024,553 | -36.9% | 860,135 | -12.0% | 0.01% | -37.5% |
Q2 2023 | $25,405,034 | -9.6% | 977,862 | -0.0% | 0.01% | -11.1% |
Q1 2023 | $28,096,203 | +98795.5% | 978,300 | +1.9% | 0.01% | +12.5% |
Q4 2022 | $28,410 | -99.9% | 959,746 | +2.1% | 0.01% | -11.1% |
Q3 2022 | $22,367,000 | +11.2% | 939,802 | +4.3% | 0.01% | +28.6% |
Q2 2022 | $20,108,000 | -8.0% | 900,887 | +3.5% | 0.01% | 0.0% |
Q1 2022 | $21,853,000 | -28.8% | 870,299 | +1.7% | 0.01% | -22.2% |
Q4 2021 | $30,675,000 | -16.4% | 856,124 | -0.7% | 0.01% | -25.0% |
Q3 2021 | $36,683,000 | -0.7% | 861,933 | +1.0% | 0.01% | 0.0% |
Q2 2021 | $36,958,000 | +5.0% | 853,720 | -0.8% | 0.01% | 0.0% |
Q1 2021 | $35,186,000 | -12.1% | 860,554 | -2.7% | 0.01% | -14.3% |
Q4 2020 | $40,015,000 | +22.7% | 884,116 | -4.1% | 0.01% | 0.0% |
Q3 2020 | $32,613,000 | -7.2% | 921,580 | -1.0% | 0.01% | -6.7% |
Q2 2020 | $35,137,000 | +29.0% | 931,332 | -1.2% | 0.02% | +7.1% |
Q1 2020 | $27,240,000 | -47.5% | 942,233 | -5.9% | 0.01% | -26.3% |
Q4 2019 | $51,917,000 | -9.5% | 1,001,294 | -4.2% | 0.02% | -13.6% |
Q3 2019 | $57,359,000 | +34.6% | 1,044,991 | -0.4% | 0.02% | +29.4% |
Q2 2019 | $42,622,000 | +37.6% | 1,049,305 | +2.5% | 0.02% | +41.7% |
Q1 2019 | $30,971,000 | -7.6% | 1,024,179 | +2.7% | 0.01% | -20.0% |
Q4 2018 | $33,523,000 | -20.3% | 997,441 | -0.0% | 0.02% | -6.2% |
Q3 2018 | $42,074,000 | +34.5% | 997,485 | +2.0% | 0.02% | +33.3% |
Q2 2018 | $31,282,000 | -32.4% | 977,569 | +5.0% | 0.01% | -36.8% |
Q1 2018 | $46,278,000 | -4.8% | 930,771 | +3.3% | 0.02% | -5.0% |
Q4 2017 | $48,589,000 | -6.5% | 901,304 | +0.6% | 0.02% | -13.0% |
Q3 2017 | $51,945,000 | +19.9% | 895,600 | +2.0% | 0.02% | +15.0% |
Q2 2017 | $43,321,000 | +29.2% | 878,006 | +13.8% | 0.02% | +25.0% |
Q1 2017 | $33,522,000 | -6.4% | 771,699 | +5.5% | 0.02% | -11.1% |
Q4 2016 | $35,823,000 | +2.6% | 731,679 | +0.2% | 0.02% | -5.3% |
Q3 2016 | $34,926,000 | -13.0% | 729,924 | -2.4% | 0.02% | -17.4% |
Q2 2016 | $40,134,000 | +14.9% | 748,083 | -4.2% | 0.02% | +9.5% |
Q1 2016 | $34,935,000 | +18.1% | 781,196 | +0.8% | 0.02% | +16.7% |
Q4 2015 | $29,575,000 | +26.6% | 775,025 | +5.6% | 0.02% | +20.0% |
Q3 2015 | $23,359,000 | -1.6% | 733,870 | +2.1% | 0.02% | 0.0% |
Q2 2015 | $23,750,000 | -18.9% | 719,061 | +1.1% | 0.02% | -16.7% |
Q1 2015 | $29,281,000 | -10.5% | 711,225 | -11.4% | 0.02% | -14.3% |
Q4 2014 | $32,717,000 | -6.0% | 803,068 | -15.4% | 0.02% | -16.0% |
Q3 2014 | $34,789,000 | -21.1% | 948,932 | -0.2% | 0.02% | -19.4% |
Q2 2014 | $44,066,000 | +15.2% | 951,130 | +2.2% | 0.03% | +6.9% |
Q1 2014 | $38,242,000 | +9.3% | 930,486 | +1.5% | 0.03% | +7.4% |
Q4 2013 | $34,980,000 | +66.1% | 916,678 | +4.3% | 0.03% | +50.0% |
Q3 2013 | $21,057,000 | +47.7% | 878,814 | +4.8% | 0.02% | +38.5% |
Q2 2013 | $14,258,000 | – | 838,712 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |